The treatment of patients with drug abuse is limited by a shortage of physicians qualified to conduct clinical addiction research and trained to translate research advances into practice. Both generalist physicians and infectious disease subspecialists, who provide care for patients with HIV and Hepatitis C (HCV) infections lack expertise in addiction medicine. These workforce gaps limit the advancement, translation, and dissemination of drug abuse research. This renewal grant - led by established physician-researchers at Boston Medical Center and the Boston University School of Medicine - will advance the Clinical Addiction Research and Education (CARE) Program, which has successfully fostered physician development in addiction research and education over the past 9 years. The CARE Program will pursue the following Specific Aims: 1. To carry out an Immersion Training in Addiction Medicine in order to: a. Train Chief Resident (CR) educators and their faculty mentors to teach state-of-the-art clinical care of patients with substance use by hosting the Chief Resident Immersion Training (CRIT) to build addiction medicine clinical skills including identification, assessment and management of drug and unhealthy alcohol use;CRIT will also highlight clinical research careers focused on drug abuse. b. Prepare fellows from Infectious Disease (ID) or other subspecialty programs training in HIV/HCV to incorporate drug abuse issues into research, teaching and clinical practice by hosting a Fellow Immersion Training (FIT), which will run in collaboration with CRIT;fellows will have additional focused exposure to clinical addiction research by CARE Program faculty. 2. To support medical trainees and early career physician faculty in the development of clinical research careers in drug abuse by recruiting medical students, residents, fellows and junior faculty to be mentored by CARE Program faculty on drug abuse research projects. 3. To support physicians and drug abuse researchers to be current on clinically relevant drug abuse research and research ethics including advances related to HIV and HCV by expanding on the website and research summary newsletter Alcohol, Other Drugs and Health: Current Evidence. The CARE program is a comprehensive effort to train a spectrum of physicians-in-training (i.e, from medical students to junior faculty) in clinical research methods, pharmacologic advances, medical complications, and other dimensions of care of patients with or at risk for drug abuse and dependence.

Public Health Relevance

The CARE Program is significant because it will make important contributions to the development of the next generation of physician drug abuse researchers, educators and clinicians and to the dissemination of addiction research to advance the care of patients. Both will ultimately improve patient care and reduce the medical, social, and financial burden of drug abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Education Projects (R25)
Project #
5R25DA013582-14
Application #
8655525
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Kahana, Shoshana Y
Project Start
2001-05-01
Project End
2016-04-30
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
14
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Boston Medical Center
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02118
Tsui, Judith I; Lira, Marlene C; Cheng, Debbie M et al. (2016) Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug Alcohol Depend 166:26-31
Noska, Amanda J; Roberts, Mary B; Sufrin, Carolyn et al. (2016) History of Sex Exchange in Women with a History of Incarceration. J Health Care Poor Underserved 27:149-62
LaBelle, Colleen T; Han, Steve Choongheon; Bergeron, Alexis et al. (2016) Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers. J Subst Abuse Treat 60:6-13
Fairbairn, Nadia S; Walley, Alexander Y; Cheng, Debbie M et al. (2016) Mortality in HIV-Infected Alcohol and Drug Users in St. Petersburg, Russia. PLoS One 11:e0166539
Thakarar, Kinna; Weinstein, Zoe M; Walley, Alexander Y (2016) Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgrad Med J 92:356-63
Tsui, Judith I; Cheng, Debbie M; Quinn, Emily et al. (2016) Pain and Mortality Risk in a Cohort of HIV-Infected Persons with Alcohol Use Disorders. AIDS Behav 20:583-9
Carey, Katelyn J; Huang, Wei; Linas, Benjamin P et al. (2016) Hepatitis C Virus Testing and Treatment Among Persons Receiving Buprenorphine in an Office-Based Program for Opioid Use Disorders. J Subst Abuse Treat 66:54-9
Wurcel, Alysse G; Anderson, Jordan E; Chui, Kenneth K H et al. (2016) Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs. Open Forum Infect Dis 3:ofw157
Wurcel, Alysse G; Merchant, Elisabeth A; Clark, Roger P et al. (2015) Emerging and Underrecognized Complications of Illicit Drug Use. Clin Infect Dis 61:1840-9
Lunze, Karsten; Lunze, Fatima I; Raj, Anita et al. (2015) Stigma and Human Rights Abuses against People Who Inject Drugs in Russia--A Qualitative Investigation to Inform Policy and Public Health Strategies. PLoS One 10:e0136030

Showing the most recent 10 out of 40 publications